Navigation Links
Angioplasty death risk reduced by doubling drug dose

A new study shows how the risk of death and heart attack can be reduced for heart patients undergoing an angioplasty. It was found that doubling the usual dose of an anti-clotting drug before the procedure is the answer.//

Angioplasty is a procedure in which a balloon-tipped catheter is threaded into an artery. The balloon is inflated to compress plaque in the artery and unblock the vessel. A small synthetic tube - stent is used to hold the vessel open, but arteries often re-close if blood clots form to protect the body against bleeding.

Patients commonly take the drug clopidogrel (Plavix) before angioplasty to prevent clotting. In this new study, patients received either the standard dose of 300 milligrams or received a dose of 600 milligrams before the procedure.

Following angioplasty it was found out that, 12 percent of patients who took the lower dose died, had a heart attack or needed another procedure. In contrast, only 4 percent of patients in the high-dose group had such an event. Doubling the dosage did not increase the risk of bleeding.

In conclusion, it was evident that the high-dose patients had a 48-percent reduction in heart attack risk compared to those given the standard dose. Additionally, a subgroup of patients taking the higher dose as well as the cholesterol-lowering drugs called statins had an 80-percent reduction.

Page: 1

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. Angioplasty Should be the Standard
3. The Success Rate Of Angioplasty In Female Patients Low
4. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
5. Angioplasty death risk reduced by doubling drug dose
6. A ray of hope in Angioplasty dilemma
7. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
8. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
9. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Togadiyas Condition Stable After Undergoing Angioplasty
Post Your Comments:

(Date:10/13/2015)... ... October 13, 2015 , ... ... development solutions for drugs, biologics, consumer health and animal health products, today announced ... will lead a new, dedicated global team of drug development and technology experts. ...
(Date:10/12/2015)... Nashville, TN (PRWEB) , ... October 13, 2015 ... ... the recipients of its biannual Heroes in Recovery Awards at Foundations Recovery Network’s ... Foundations Recovery Network presented the one-of-a-kind awards to Noah Levine and Dean Dauphinais ...
(Date:10/12/2015)... ... October 13, 2015 , ... North American Tool Corporation has been named ... National Meeting in Rosemont, IL on October 4th. , Each year, ... excellence that customers have come to expect from members of IBC’s marketing group. ...
(Date:10/12/2015)... ... ... of the “Check-In and Win a Vacation to Hawaii” Facebook contest at Gold’s Gym ... didn’t believe I could win a free vacation simply by checking in on Facebook every ... and invest in my own health – and now I’m going to Hawaii.” , Thanks ...
(Date:10/12/2015)... ... , ... Amerec , a leader in the steam and sauna industry, ... be displaying custom sauna and steam room solutions at the ISPA Conference & Expo ... customers, SpaEquip is recognized for their ability to assist in the design and implementation ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Minn. , Oct. 12, 2015 Device ... a need to help integrate these devices into existing ... of ergonomic healthcare mounting and mobility solutions, has launched ... lightest cart yet, for a wide array of laptops ... Cart SV10 was developed exclusively for Microsoft Surface and ...
(Date:10/12/2015)... , October 12, 2015 ... Forecast to grow at 7.2% CAGR, microscopy ... by rising focus on nanotechnology, technological advancements, ... research report available with ... . --> Complete report ...
(Date:10/12/2015)... England , Oct. 12, 2015 Indivior PLC ... the District of Delaware granted the ... Teva Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to ... SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in ... --> Since August 2013, Indivior has received Paragraph ...
Breaking Medicine Technology: